jRCT2031210362已完成不适用
MND-2119 Clinical Pharmacology Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 40age old under（—）
- 性别
- Male
入选标准
- •Male participants willing to participate in this clinical trial with the ability to consent and provide written consent
排除标准
- •Participants with or with a history of, cardiac, hepatic, renal, respiratory, hematologic, gastrointestinal, thyroid gland, psychological, neurologic, metabolic, and electrolyte disorders that are considered by the principal (or sub-) investigator as ineligible to participate in the study
结局指标
主要结局
-
Fatty acid composition of plasma and blood cells Leukocyte-derived EPA metabolites Cytokine
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
TO-208 Clinical Pharmacology StudyMolluscum ContagiosumjRCT2031230204Torii Pharmaceutical Co.,Ltd18
已完成
不适用
Clinical pharmacology study to evaluate the drug-drug interactions of TAS-115 in healthy subjectsjRCT2071210113Taiho Pharmaceutical Co., Ltd.60
已完成
1 期
Clinical pharmacology study to evaluate the drug-drug interactions of TAS-115 in healthy subjectsChronic fibrosing interstitial lung diseases with a progressive phenotypeJPRN-jRCT2071210113Jinhong Huang60
尚未招募
3 期
Comparative Clinical Study of Kariradi Vaginal Wash and Clotrimazole in ShwetapradarCTRI/2024/07/069717DrApurva Chandrakant Karande
招募中
不适用
Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.Colorectal CancerJPRN-UMIN000013939Showa University School of Medicine100